In vivo veritas: Bcl-2 and Bcl-XLmediate tumor cell resistance to chemotherapy
- 1 June 2000
- journal article
- Published by Elsevier in Drug Resistance Updates
- Vol. 3 (3) , 149-154
- https://doi.org/10.1054/drup.2000.0142
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 46 references indexed in Scilit:
- Cleavage and inactivation of antiapoptotic Akt/PKB by caspases during apoptosisJournal of Cellular Physiology, 2000
- p21Waf1/cip1 acts in synergy with bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell lineInternational Journal of Cancer, 1999
- A Human IAP-Family Gene, Apollon, Expressed in Human Brain Cancer CellsBiochemical and Biophysical Research Communications, 1999
- Activation and role of caspases in chemotherapy-induced apoptosisDrug Resistance Updates, 1999
- Involvement of Bcl-2 Cleavage in the Acceleration of VP-16-Induced U937 Cell ApoptosisBiochemical and Biophysical Research Communications, 1998
- Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase AktScience, 1997
- Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of ApoptosisScience, 1997
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- MECHANISMS OF MULTIDRUG RESISTANCE AND IMPLICATIONS FOR THERAPYJapanese Journal of Cancer Research, 1988